From preclinical development through commercial supply.
Vetter Pharma is a development partner for prefilled syringes and injection devices for drug delivery.
As a contract development and manufacturing organisation (CDMO), the company’s comprehensive resources support customers from initial clinical development phases through to product launch.
Vetter Pharma guides clients through international regulatory requirements to ensure adherence with guidelines, as well as supports commercial production and life cycle management.
Vetter Pharma helps provide stability to the often unpredictable period from preclinical drug development through to Phase III clinical trials. It supports partners throughout product development, including clinical manufacturing and regulatory approval.
The company also provides clinical fill/finish for a wide range of batch sizes and a variety of injection systems, ranging from vials to syringes and cartridges.
To ensure products are high-quality Vetter Pharma consistently invests in its technology and uses its comprehensive know-how in
In addition, Vetter Pharma’s clinical manufacturing capabilities in the US and Europe streamlines the path to clinical trials, which is complemented with the firm’s dedicated project management.
Vetter Pharma manages the clinical batch release of a compound, ensuring projects are completed within a specified timescale.
The company provides early phase clinical trial manufacturing for a wide range of vials, prefilled syringes and cartridges. Flexible filling lines also allow Vetter to provide a range of clinical batch sizes to meet specific needs and requirements.
Vetter Pharma provides clinical pharmaceutical manufacturing services for Phase I to Phase III drugs, including
Vetter Pharma has decades of experience as a contract manufacturer, providing fill and finish for injectable drugs. This delivers results for pharmaceutical and biotechnology companies requiring close integration of sophisticated resources and technologies.
The company also delivers high-quality services to solve supply chain challenges.
Vetter Pharma offers aseptic fill/finish services for parenteral drug manufacturing, including liquid and lyophilised products in vials, syringes and cartridges.
The company supports customers in activities ranging from development to packaging, including manufacturing services for both clinical and commercial drug products.
Vetter Pharma supports drug candidates through all phases of regulatory submission. It has a high success record with global regulatory agencies such as the US Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan.
The company’s chemistry, manufacturing and control (CMC), current good manufacturing practice (cGMP), and quality assurance QA experts support:
Vetter Pharma is experienced with designing packaging for every stage of a product’s lifecycle. It identifies and develops packaging strategies, ensuring that the material is patient-friendly, it is easy-to-assemble and has suitable safety elements to protect the drug.
The company’s packaging and injectable delivery systems can be customised to product’s specific requirements, including:
Vetter Pharma offers a portfolio of packaging solutions from the aseptic filling of conventional delivery systems to specialised and novel technologies that help differentiate a product in the market and extend its lifecycle. Vetter’s injectable delivery systems are available in a wide array of configurations.
Vetter is a family-owned, independent company and does not manufacture its own drugs. It is headquartered in Ravensburg, Germany.
Vetter Pharma International GmbH